Contributors: Special thanks to Baris Gencer from the ESC Working Groups on Cardiovascular Pharmacotherapy, Cardiovascular Surgery, Coronary Pathophysiology and Microcirculation, Thrombosis.
Based on the 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Webinars on this topic
ESC webinar on "Non-ST elevation acute coronary syndromes : what is new in the 2015 ESC Guidelines?" streamed live on 14 December 2015: Watch the recording.
Part 1 - Overview of the ESC 2015 Guidelines on NSTE-ACS
| Session Title |
Slides |
Webcast |
|
ESC congress highlights- Acute coronary syndromes and acute cardiac care
|
|
|
|
Meet the Task Force II
|
|
|
|
Meet the Task Force II - panel discussion
|
|
|
|
Antithrombotic treatment
|
|
|
| Diagnostic and risk assessment |
|
|
| Invasive strategies and revascularization |
|
|
| Special populations and conditions |
|
|
| What do the guidelines say? |
|
|
Part 2 - Topics in focus
| Session Title |
Slides |
Webcast |
| Challenges in troponin interpretation |
|
|
| Acute pulmonary oedema and atrial fibrillation with elevated troponin. |
|
|
| Acute pulmonary oedema and atrial fibrillation with elevated troponin - Panel discussion and questions from the audience. |
|
|
| Positive troponin after cardiac surgery - Panel discussion and questions from the audience. |
|
|
| Positive troponin after cardiac surgery. |
|
|
| Challenges in troponin interpretation. State of the Art lecture |
|
|
| Advances in Science - Post infarction period |
|
|
| State of the Art in risk assessment of patients post myocardial infarction. |
|
|
Chronology of events after hospital discharge following acute myocardial infarction is not uniform. Five-year follow-up of the FAST-MI 2005 registry
|
|
|
Long term relative survival and excess mortality after acute myocardial infarction, 2003-2010: a national cohort study
|
|
|
| Optimising management of ACS in different patient subgroups |
|
|
| Elderly |
|
|
| Women |
|
|
| Diabetics |
|
|
| Atrial Fibrillation patients. |
|
|
Meet the experts
|
|
|
| Difficult cases in acute coronary syndromes revascularisation in clinical practice - Introduction to the session. |
|
|
NSTEMI case with three vessel disease.
|
|
|
| NSTEMI case with three vessel disease - Panel discussion and questions from the audience. |
|
|
| STEMI case with three vessel disease. |
|
|
| STEMI case with three vessel disease - Panel discussion and questions from the audience. |
|
|
Guidelines in Daily Practice
|
|
|
| What do the new ESC guidelines tell us in Germany - case presentation |
|
|
| Acute coronary syndromes NSTEMI in Germany: What do the "new" 2015 Guidelines tell us? |
|
|
| What do the new ESC guidelines tell us in Serbia -case presentation |
|
|
| Acute coronary syndromes NSTEMI in Serbia: What do the "new" 2015 Guidelines tell us? |
|
|
| NSTEMI guidelines: helpful in real world? NSTEMi and Afib |
|
|
| NSTEMI and atrial fibrillation |
|
|
| NSTEMI and atrial fibrillation - What do the Guidelines say? |
|
|
| NSTEMI and atrial fibrillation - Panel discussion on how to implement the Guidelines |
|
|
| NSTEMI and atrial fibrillation - Conclusion and take home message. |
|
|
| NSTEMI guidelines: helpful in real world? Pre treatment in NSTEMI |
|
|
| Pre treatment in NSTEMI |
|
|
| Pre treatment in NSTEMI - What do the Guidelines say? |
|
|
| Pre treatment in NSTEMI - Panel discussion on how to implement the Guidelines |
|
|
| Pre treatment in NSTEMI - Conclusion and take home message. |
|
|
Our mission: To reduce the burden of cardiovascular disease.